Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia
暂无分享,去创建一个
P. Marlton | D. DeAngelo | J. Liesveld | A. Advani | E. Feldman | D. Bixby | J. Magnani | H. Thackray | P. Becker | M. O'Dwyer | B. Jonas